Stock
(Reuters) – Drugmaker Biogen (NASDAQ:BIIB) will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 apiece, a filing...
Hi, what are you looking for?
(Reuters) – Meta (NASDAQ:META) CEO Mark Zuckerberg met with U.S. President-elect Donald Trump at Mar-a-Lago on Friday, Semafor news website reported, citing a source...
(Reuters) – Drugmaker Biogen (NASDAQ:BIIB) will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 apiece, a filing...
WASHINGTON (Reuters) -Taiwan Semiconductor Manufacturing Co has begun producing advanced 4-nanometer chips for U.S. customers in Arizona, Commerce Secretary Gina Raimondo told Reuters, a...
BERLIN (Reuters) – The number of people out of work in Germany rose less than expected in December, federal labour office figures showed on...
COPENHAGEN (Reuters) -Norway’s sovereign wealth fund said on Friday it had acquired a 45% stake in a portfolio of logistics properties in the United...
LONDON (Reuters) – The first full trading week of 2025 brings key U.S. jobs data as well as Chinese and euro zone inflation numbers....
(Reuters) – Demand for global equity funds shrank in the week through Jan. 1, as higher U.S. Treasury yields led to caution and investors...
Investing.com — The S&P 500 faces downside risks in January, according to Jonathan Krinsky, a chief market technician at BTIG. In a Thursday note,...